-The Economic Times MUMBAI: In a victory to generic drugmakers, the Intellectual Property Appellate Board (IPAB) of Chennai has dismissed German pharma major Bayer's plea, seeking a stay on the Compulsory Licence issued to Hyderabad-based drugmaker Natco. The Compulsory Licence (CL) issued by the Controller of Patents in March this year allowed Natco to make and sell a generic version of Nexavar - used for treating liver and kidney cancer - at...
More »SEARCH RESULT
Cipla wins patent case over Tarceva -CH Unnikrishnan
-Live Mint Cipla Ltd won a landmark patent case against Swiss drug maker F Hoffmann-La Roche Ltd in the Delhi high court on Friday over the Indian company’s generic copy of lung cancer drug Tarceva after a four-year court battle. Justice Manmohan Singh observed in his 280-page judgement that it had been scientifically proven that Cipla’s generic version was a polymorph B variant of Roche’s patented drug and that it didn’t actually...
More »Dr Anand Teltumbde, Dalit intellectual, thinker and human rights activist interviewed by Prasanna D Zore
-Rediff.com On July 14, the Nagpur bench of the Bombay high court commuted the death sentence awarded to six convicts in the Khairlanji murder case to 25 years' rigorous imprisonment. On September 29, 2006, a mob brutally raped a mother and daughter before killing them along with her two sons. Surekha Bhotmange (then 42), Priyanka Bhotmange (17), Roshan Bhotmange (19) and Sudhir Bhotmange (21) belonged to one of the three Dalit families...
More »Natco targets drugs ripe for compulsory licensing-Viswanath Pilla
-Live Mint Natco Pharma Ltd, which has started selling a generic version of Bayer AG’s patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm, plans to use the so-called compulsory licensing route to try and win the right to copy more patented drugs, said vice-chairman and chief executive officer Rajeev Nannapaneni. The Hyderabad-based company has already identified the patented drugs for which it will...
More »UN-backed commission finds that punitive laws stifling global AIDS response
-The United Nations Punitive laws and human rights abuses are costing lives, wasting money and stifling the global AIDS response, according to a report released today by a United Nations-backed commission. Entitled HIV and the Law: Risks, Rights and Health, the report by the Global Commission on HIV and the Law – made up of former heads of state and leading legal, human rights and HIV experts, and supported by the UN...
More »